Alert-Based Care for Pacemaker Patients

(RAPTOR - MAIN Trial)

DB
Overseen ByDaniel B Kramer, MD, MPH
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Beth Israel Deaconess Medical Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

he Remote Alert Pathway to Optimize Care of Cardiac Implantable Electrical Devices (RAPTOR-CIED) Study is a pragmatic, multi-center, randomized trial with 1:1 patient-level randomization comparing the safety and effectiveness of alert-driven care versus guideline-based care for patients with wireless cardiac implantable electrical devices (CIEDs).

The study will be conducted in 2 phases: a Feasibility Phase and a Main Phase. This registration outlines the goals and design features of the Main Phase of the study.

Are You a Good Fit for This Trial?

The RAPTOR-CIED Study is for adults over 18 with a wireless cardiac device like pacemakers or defibrillators. They must be clinically stable, have devices from major US manufacturers, enrolled in remote monitoring, and followed up at the study center. Understanding English, Spanish, or Portuguese and being able to comprehend the study are also required.

Inclusion Criteria

I have a pacemaker or defibrillator implanted.
My cardiac device is made by Medtronic, Boston Scientific, Abbott, or Biotronik.
I am enrolled in a remote monitoring program as part of my treatment.
See 5 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Main Phase

Participants are randomized to either alert-driven care or guideline-based care for management of cardiac implantable electrical devices

2 years
Routine transmissions every 90 days, annual in-office interrogations

Follow-up

Participants are monitored for safety and effectiveness after the main phase

4-8 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Alert-based Care
  • Guideline-based Care

Trial Overview

This trial compares two types of care for patients with cardiac devices: alert-driven care where doctors respond to signals from the device versus standard guideline-based care. It's randomized so patients have equal chances of being in either group.

How Is the Trial Designed?

2

Treatment groups

Active Control

Group I: Guideline-based CareActive Control1 Intervention
Group II: Alert-based careActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Beth Israel Deaconess Medical Center

Lead Sponsor

Trials
872
Recruited
12,930,000+

Patient-Centered Outcomes Research Institute

Collaborator

Trials
592
Recruited
27,110,000+